首页> 外国专利> Tetrahydroisoquinoline TETRAGIDROBENZAZEPINOVYE AND DERIVATIVES (OPTIONS), pharmaceutical compositions and pharmaceutical kits, medicinal and reference instruments for the test-systems based on them, methods of treatment and prevention of diseases in which the down-regulation of a favorable or inhibiting the expression or function of IGF-1 Receptor

Tetrahydroisoquinoline TETRAGIDROBENZAZEPINOVYE AND DERIVATIVES (OPTIONS), pharmaceutical compositions and pharmaceutical kits, medicinal and reference instruments for the test-systems based on them, methods of treatment and prevention of diseases in which the down-regulation of a favorable or inhibiting the expression or function of IGF-1 Receptor

机译:四氢异喹啉TETRAGIDROBENZAZEPINOVYE和衍生物(OPTIONS),药物组合物和药物试剂盒,用于基于它们的测试系统的药物和参考仪器,治疗方法和预防方法IGF-1受体

摘要

The compounds of formula (I) are synthesized in which R, R, R have the meanings as described, and U, V and W, respectively, can be CR ', CR' and CR ', (with the definitions of R', R ' and R 'again, as described) or may mean N. It is shown that they down-regulate or inhibit the expression or function of the IGF-1 receptor.
机译:合成了式(I)的化合物,其中R 1,R 2,R 3具有所描述的含义,并且U,V和W分别可以是CR',CR'和CR'(具有R'的定义, R′和R′再次如所述)或可以表示N。表明它们下调或抑制IGF-1受体的表达或功能。

著录项

  • 公开/公告号EA200601687A1

    专利类型

  • 公开/公告日2007-04-27

    原文格式PDF

  • 申请/专利权人 АНАЛИТИКОН С.А.;

    申请/专利号EA20060001687

  • 申请日2004-03-12

  • 分类号C07D217/14;A61K31/472;A61K31/4725;A61P35;C07D217/16;C07D233/16;C07D401/04;

  • 国家 EA

  • 入库时间 2022-08-21 20:58:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号